BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29290796)

  • 1. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.
    Li L; Xie H; Liang L; Gao Y; Zhang D; Fang L; Lee SO; Luo J; Chen X; Wang X; Chang LS; Yeh S; Wang Y; He D; Chang C
    Carcinogenesis; 2013 Feb; 34(2):257-67. PubMed ID: 23104178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cafestol inhibits colon cancer cell proliferation and tumor growth in xenograft mice by activating LKB1/AMPK/ULK1-dependent autophagy.
    Feng Y; Yang J; Wang Y; Wang X; Ma Q; Li Y; Zhang X; Wang S; Zhang Q; Mi F; Wang Y; Zhong D; Yin J
    J Nutr Biochem; 2024 Jul; 129():109623. PubMed ID: 38492819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
    Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
    J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway.
    Liu W; Wang X; Liu Z; Wang Y; Yin B; Yu P; Duan X; Liao Z; Chen Y; Liu C; Li X; Dai Y; Tao Z
    Br J Cancer; 2017 Oct; 117(8):1139-1153. PubMed ID: 29017179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo.
    Kobayashi T; Inoue T; Shimizu Y; Terada N; Maeno A; Kajita Y; Yamasaki T; Kamba T; Toda Y; Mikami Y; Yamada T; Kamoto T; Ogawa O; Nakamura E
    Mol Endocrinol; 2010 Apr; 24(4):722-34. PubMed ID: 20203103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.
    Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X
    Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.
    Li N; Wang Y; Neri S; Zhen Y; Fong LWR; Qiao Y; Li X; Chen Z; Stephan C; Deng W; Ye R; Jiang W; Zhang S; Yu Y; Hung MC; Chen J; Lin SH
    Nat Commun; 2019 Sep; 10(1):4363. PubMed ID: 31554794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
    Gjyrezi A; Xie F; Voznesensky O; Khanna P; Calagua C; Bai Y; Kung J; Wu J; Corey E; Montgomery B; Mace S; Gianolio DA; Bubley GJ; Balk SP; Giannakakou P; Bhatt RS
    J Clin Invest; 2020 Jun; 130(6):3287-3298. PubMed ID: 32478682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells.
    Pu YS; Huang CY; Wu HL; Wu JH; Su YF; Yu CR; Lu CY; Wu WJ; Huang SP; Huang YT; Hour TC
    Kaohsiung J Med Sci; 2024 Jan; 40(1):23-34. PubMed ID: 37916740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer.
    Wang Y; Xu L; Shi S; Wu S; Meng R; Chen H; Jiang Z
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.
    Nalairndran G; Chung I; Abdul Razack AH; Chung FF; Hii LW; Lim WM; Looi CK; Mai CW; Leong CO
    J Cell Mol Med; 2021 Sep; 25(17):8187-8200. PubMed ID: 34322995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival.
    Nalairndran G; Hassan Abdul Razack A; Mai CW; Fei-Lei Chung F; Chan KK; Hii LW; Lim WM; Chung I; Leong CO
    J Cell Mol Med; 2020 Oct; 24(20):12188-12198. PubMed ID: 32926495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK potentiation by LKB1 isoforms.
    Thibert C; Perret C; Billaud M
    Oncotarget; 2015 Nov; 6(34):35139-40. PubMed ID: 26486087
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.
    Wang JQ; DeChalus A; Chatterjee DN; Keller ET; Mizokami A; Camussi G; Mendelsohn AR; Renzulli Ii JF; Quesenberry PJ; Chatterjee D
    Crit Rev Oncog; 2015; 20(5-6):407-17. PubMed ID: 27279238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
    Cheng B; Li L; Luo T; Wang Q; Luo Y; Bai S; Li K; Lai Y; Huang H
    J Exp Clin Cancer Res; 2024 Mar; 43(1):67. PubMed ID: 38429845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy.
    Lemos G; Fernandes CMAS; Silva FH; Calmasini FB
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):230-238. PubMed ID: 38297152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.
    Tan Q; Joshua AM; Saggar JK; Yu M; Wang M; Kanga N; Zhang JY; Chen X; Wouters BG; Tannock IF
    Br J Cancer; 2015 Mar; 112(5):832-40. PubMed ID: 25647012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAPN2 promotes apalutamide resistance in metastatic hormone-sensitive prostate cancer by activating protective autophagy.
    Qi Z; Bai X; Wu L; Zhang P; Guo Z; Yu Y
    J Transl Med; 2024 Jun; 22(1):538. PubMed ID: 38844946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.
    Bort A; Quesada S; Ramos-Torres Á; Gargantilla M; Priego EM; Raynal S; Lepifre F; Gasalla JM; Rodriguez-Henche N; Castro A; Díaz-Laviada I
    Sci Rep; 2018 Mar; 8(1):4370. PubMed ID: 29531259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.